{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:34:45Z","timestamp":1787578485429,"version":"build-2736575974"},"reference-count":65,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>Intrapatient variability (IPV) is the changes of a drug\u2019s blood trough concentration in a patient. There is a lack of consensus on whether high IPV is associated with poor outcomes in transplantation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>Several electronic databases, including MEDLINE\/PubMed, Embase, Web of Science, Cochrane Reviews, and the Cochrane CENTRAL Register of Controlled Trials, served as sources for the literature search. Covidence facilitated the sorting and extraction of data. The meta-analysis was conducted using R Studio.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>About 5210 studies were identified in initial database searches, with 41 articles ultimately included in this review. We reviewed outcomes, including acute rejection, chronic rejection, allograft survival, patient survival, and development of de novo donor-specific antibodies (dnDSA). Numerous papers supported the conjecture high IPV was associated with increased rejection rates and worse allograft survival rates, while for patient survival, chronic rejection, and dnDSA development results were equivocal regarding the effect of IPV. Meta-analysis showed that patients with low IPV had a 44% lower risk of acute rejection compared with patients with high IPV (RR = 0.56). Patients with high IPV had an increased risk of graft loss, HR = 2.42 (95% CI, 1.70-3.46).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>Our analysis showed that acute rejection and allograft survival are impacted by high IPV. In conclusion, this study establishes high IPV as a significant modifiable risk factor for acute rejection and graft loss, warranting its integration into routine clinical monitoring.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000005785","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T12:00:16Z","timestamp":1781870416000},"page":"e1927-e1945","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Intrapatient Immunosuppression Variability in Renal Transplantation Outcomes: A Systematic Review and Meta-analysis"],"prefix":"10.1097","volume":"110","author":[{"given":"Sherene","family":"Lattimore","sequence":"first","affiliation":[{"name":"Department of Surgery, University of Florida, Gainesville, FL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Chambers","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Florida, Gainesville, FL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Angeli-Pahim","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Florida, Gainesville, FL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Shrestha","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Florida, Gainesville, FL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin O.","family":"Eke","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Florida, Gainesville, FL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Pomputius","sequence":"additional","affiliation":[{"name":"University of Florida, Gainesville, FL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carma L.","family":"Bylund","sequence":"additional","affiliation":[{"name":"Department of Health Outcomes and Biomedical Informatics, University of Florida, Gainesville, FL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan E.","family":"Gregory","sequence":"additional","affiliation":[{"name":"Department of Health Outcomes and Biomedical Informatics, University of Florida, Gainesville, FL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Zarrinpar","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Transplantation and Hepatobiliary Surgery, University of Florida, Gainesville, FL."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"R2-20260824","doi-asserted-by":"crossref","first-page":"116226","DOI":"10.1016\/j.socscimed.2023.116226","article-title":"How to effectively communicate health information on social media depending on the audience\u2019s personality traits: An experimental study in the context of organ donation in Germany.","volume":"335","author":"Olsacher","year":"2023","journal-title":"Soc Sci Med"},{"key":"R3-20260824","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/TP.0b013e31822dc34f","article-title":"Monitoring nonadherence and acute rejection with variation in blood immunosuppressant levels in pediatric renal transplantation.","volume":"92","author":"Hsiau","year":"2011","journal-title":"Transplantation"},{"key":"R4-20260824","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13058","article-title":"Variability index of tacrolimus serum levels in pediatric liver transplant recipients younger than 12 years: Non-adherence or risk of non-adherence?","volume":"21","author":"de Oliveira","year":"2017","journal-title":"Pediatr Transplant"},{"key":"R5-20260824","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1590\/s0004-2803.202100000-62","article-title":"LIVER TRANSPLANTATION: TACROLIMUS BLOOD LEVELS VARIATION AND SURVIVAL, REJECTION AND DEATH OUTCOMES.","volume":"58","author":"Maciel","year":"2021","journal-title":"Arq Gastroenterol"},{"key":"R6-20260824","doi-asserted-by":"crossref","first-page":"e13388","DOI":"10.1111\/petr.13388","article-title":"Intra-patient variability in tacrolimus exposure in pediatric liver transplant recipients: evolution, risk factors, and impact on patient outcomes.","volume":"23","author":"Defrancq","year":"2019","journal-title":"Pediatr Transplant"},{"key":"R7-20260824","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1093\/ndt\/gfq096","article-title":"High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation.","volume":"25","author":"Borra","year":"2010","journal-title":"Nephrol Dial"},{"key":"R8-20260824","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0149-2918(02)85038-X","article-title":"Therapeutic drug monitoring of immunosuppressant drugs in clinical practice.","volume":"24","author":"Kahan","year":"2022","journal-title":"Clin Ther"},{"key":"R9-20260824","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1111\/cts.13276","article-title":"High intrapatient variability of tacrolimus exposure associated with poorer outcomes in liver transplantation.","volume":"15","author":"Dopazo","year":"2022","journal-title":"Clin Transl Sci"},{"key":"R10-20260824","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/j.1399-3046.2010.01409.x","article-title":"Variability in tacrolimus blood levels increases the risk of late rejection and graft loss after solid organ transplantation in older children.","volume":"14","author":"Pollock-Barziv","year":"2010","journal-title":"Pediatr Transplant"},{"key":"R11-20260824","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1038\/ki.2013.465","article-title":"Time-dependent variability in tacrolimus trough blood levels is a risk factor for late kidney transplant failure.","volume":"85","author":"Sapir-Pichhadze","year":"2014","journal-title":"Kidney Int"},{"issue":"4S Suppl 2","key":"R12-20260824","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/TP.0000000000001651","article-title":"Practical recommendations for long-term management of modifiable risks in kidney and liver transplant recipients: a guidance report and clinical checklist by the consensus on managing modifiable risk in transplantation (COMMIT) group.","volume":"101","author":"Neuberger","year":"2017","journal-title":"Transplantation"},{"key":"R17-20260824","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials.","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials."},{"key":"R18-20260824","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test.","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"R19-20260824","doi-asserted-by":"crossref","first-page":"e1700","DOI":"10.1097\/TXD.0000000000001700","article-title":"Impact of intrapatient immunosuppression variability in liver transplantation outcomes: a systematic review and meta-analysis.","volume":"10","author":"Lattimore","year":"2024","journal-title":"Transplant Direct"},{"key":"R20-20260824","doi-asserted-by":"crossref","first-page":"e424","DOI":"10.1097\/TXD.0000000000000862","article-title":"High calcineurin inhibitor intrapatient variability is associated with renal allograft inflammation, chronicity, and graft loss.","volume":"5","author":"Sharma","year":"2019","journal-title":"Transplant Direct"},{"key":"R21-20260824","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0041-1345(96)00110-8","article-title":"Low intrapatient variability of blood cyclosporine levels is correlated with excellent graft survival.","volume":"29","author":"Savoldi","year":"1997","journal-title":"Transplant Proc"},{"key":"R22-20260824","doi-asserted-by":"crossref","first-page":"e0196552","DOI":"10.1371\/journal.pone.0196552","article-title":"Tacrolimus intra-patient variability is not associated with chronic active antibody mediated rejection.","volume":"13","author":"Sablik","year":"2018","journal-title":"PLoS One"},{"key":"R23-20260824","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/S0041-1345(98)00379-0","article-title":"Variability of Sandimmune pharmacokinetics in renal transplant patients.","volume":"30","author":"Wingerchuk","year":"1998","journal-title":"Transplant Proc"},{"key":"R24-20260824","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1016\/S0041-1345(98)00503-X","article-title":"Effect of variability of cyclosporine pharmacokinetics on long-term renal allograft survival.","volume":"30","author":"Markell","year":"1998","journal-title":"Transplant Proc"},{"key":"R25-20260824","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/ndt\/17.7.1310","article-title":"Impact of the variability of cyclosporin A trough levels on long-term renal allograft function.","volume":"17","author":"Waiser","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"R27-20260824","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/ndt\/gfh344","article-title":"Cyclosporin exposure correlates with 1 year graft function and histological damage in renal transplanted patients.","volume":"19","author":"di Paolo","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"R28-20260824","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1093\/ndt\/gfq096","article-title":"High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation.","volume":"25","author":"Borra","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R29-20260824","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1399-3046.2012.01727.x","article-title":"Intra-patient variability in tacrolimus trough concentrations and renal function decline in pediatric renal transplant recipients.","volume":"16","author":"Prytula","year":"2012","journal-title":"Pediatr Transplant"},{"key":"R30-20260824","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/FTD.0b013e3182731809","article-title":"Impact of tacrolimus intraindividual variability and CYP3A5 genetic polymorphism on acute rejection in kidney transplantation.","volume":"34","author":"Ro","year":"2012","journal-title":"Ther Drug Monit"},{"key":"R31-20260824","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s40620-015-0230-0","article-title":"Tacrolimus trough-level variability predicts long-term allograft survival following kidney transplantation.","volume":"29","author":"O\u2019Regan","year":"2016","journal-title":"J Nephrol"},{"key":"R32-20260824","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.transproceed.2016.02.081","article-title":"Higher variability of tacrolimus trough level increases risk of acute rejection in kidney transplant recipients.","volume":"48","author":"Huang","year":"2016","journal-title":"Transplant Proc"},{"key":"R33-20260824","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1097\/TP.0000000000001040","article-title":"Within-patient variability in tacrolimus blood levels predicts kidney graft loss and donor-specific antibody development.","volume":"100","author":"Rodrigo","year":"2016","journal-title":"Transplantation"},{"key":"R34-20260824","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/TP.0000000000001129","article-title":"High intrapatient tacrolimus variability is associated with worse outcomes in renal transplantation using a low-dose tacrolimus immunosuppressive regime.","volume":"101","author":"Whalen","year":"2017","journal-title":"Transplantation"},{"key":"R35-20260824","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/ndt\/gfw394","article-title":"Association of the combination of time-weighted variability of tacrolimus blood level and exposure to low drug levels with graft survival after kidney transplantation.","volume":"32","author":"Rozen-Zvi","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"R36-20260824","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1097\/TXD.0000000000000710","article-title":"High intrapatient variability of tacrolimus levels and outpatient clinic nonattendance are associated with inferior outcomes in renal transplant patients.","volume":"3","author":"Goodall","year":"2017","journal-title":"Transplant Direct"},{"key":"R37-20260824","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1097\/TP.0000000000001840","article-title":"Tacrolimus trough concentration variability and disparities in African American kidney transplantation.","volume":"101","author":"Taber","year":"2017","journal-title":"Transplantation"},{"key":"R38-20260824","doi-asserted-by":"crossref","first-page":"e13424","DOI":"10.1111\/ctr.13424","article-title":"Tacrolimus trough and dose intra-patient variability and CYP3A5 genotype: Effects on acute rejection and graft failure in European American and African American kidney transplant recipients.","volume":"32","author":"Seibert","year":"2018","journal-title":"Clin Transplant"},{"key":"R39-20260824","doi-asserted-by":"crossref","first-page":"e455","DOI":"10.1097\/TXD.0000000000000899","article-title":"Association of intrapatient variability of tacrolimus concentration with early deterioration of chronic histologic lesions in kidney transplantation.","volume":"5","author":"Mo","year":"2019","journal-title":"Transplant Direct"},{"key":"R40-20260824","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00228-019-02643-y","article-title":"Reduction of exposure to tacrolimus trough level variability is associated with better graft survival after kidney transplantation.","volume":"75","author":"Rahamimov","year":"2019","journal-title":"Eur J Clin Pharmacol"},{"key":"R41-20260824","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s13318-019-00544-0","article-title":"Tacrolimus variability: a cause of donor-specific anti-HLA antibody formation in children.","volume":"44","author":"Kaya Aksoy","year":"2019","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"R42-20260824","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1111\/ajt.15346","article-title":"Late intra-patient tacrolimus trough level variability as a major problem in kidney transplantation: a collaborative transplant study report.","volume":"19","author":"S\u00fcsal","year":"2019","journal-title":"Am J Transplant"},{"key":"R43-20260824","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1007\/s00467-019-04346-z","article-title":"Defining a threshold for tacrolimus intra-patient variability associated with late acute cellular rejection in paediatric kidney transplant recipients.","volume":"34","author":"Abu Bakar","year":"2019","journal-title":"Pediatr Nephrol"},{"key":"R44-20260824","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.3389\/fimmu.2019.02912","article-title":"Increasing time in therapeutic range of tacrolimus in the first year predicts better outcomes in living-donor kidney transplantation.","volume":"10","author":"Song","year":"2019","journal-title":"Front Immunol"},{"key":"R45-20260824","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00467-019-04377-6","article-title":"Tacrolimus variability is associated with de novo donor-specific antibody development in pediatric renal transplant recipients.","volume":"35","author":"Solomon","year":"2020","journal-title":"Pediatr Nephrol"},{"key":"R46-20260824","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/tri.13726","article-title":"Association of graft survival with tacrolimus exposure and late intra-patient tacrolimus variability in pediatric and young adult renal transplant recipients-an international CTS registry analysis.","volume":"33","author":"Gold","year":"2020","journal-title":"Transpl Int"},{"key":"R47-20260824","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1016\/j.transproceed.2020.07.016","article-title":"The effect of tacrolimus trough variability on kidney transplant outcomes.","volume":"52","author":"Heeney","year":"2020","journal-title":"Transplant Proc"},{"key":"R48-20260824","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.transproceed.2020.10.003","article-title":"Impact of protease inhibitor-based antiretroviral therapy on tacrolimus intrapatient variability in HIV-positive kidney transplant recipients.","volume":"53","author":"Cooper","year":"2021","journal-title":"Transplant Proc"},{"key":"R49-20260824","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/FTD.0000000000000863","article-title":"Etiologies and outcomes associated with tacrolimus levels out of a typical range that lead to high variability in kidney transplant recipients.","volume":"43","author":"Taber","year":"2021","journal-title":"Ther Drug Monit"},{"key":"R50-20260824","doi-asserted-by":"crossref","first-page":"12114","DOI":"10.1038\/s41598-021-91630-4","article-title":"Clinical significance of tacrolimus intra-patient variability on kidney transplant outcomes according to pre-transplant immunological risk.","volume":"11","author":"Kim","year":"2021","journal-title":"Sci Rep"},{"key":"R51-20260824","doi-asserted-by":"crossref","first-page":"910","DOI":"10.6002\/ect.2021.0231","article-title":"Tacrolimus trough intravariability in patients treated with the prolonged-release formulation is a risk factor for acute graft rejection.","volume":"19","author":"Mira","year":"2021","journal-title":"Exp Clin Transplant"},{"key":"R52-20260824","doi-asserted-by":"crossref","first-page":"746013","DOI":"10.3389\/fimmu.2021.746013","article-title":"Intrapatient variability in tacrolimus trough levels over 2 years affects long-term allograft outcomes of kidney transplantation.","volume":"12","author":"Park","year":"2021","journal-title":"Front Immunol"},{"key":"R53-20260824","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3390\/jpm11101002","article-title":"Impact of tacrolimus daily dose limitation in renal transplant recipients expressing CYP3A5: a retrospective study.","volume":"11","author":"Lenain","year":"2021","journal-title":"J Pers Med"},{"key":"R54-20260824","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/FTD.0000000000000955","article-title":"High tacrolimus intrapatient variability and subtherapeutic immunosuppression are associated with adverse kidney transplant outcomes.","volume":"44","author":"Mendoza Rojas","year":"2022","journal-title":"Ther Drug Monit"},{"key":"R55-20260824","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.2215\/CJN.16421221","article-title":"Patterns in tacrolimus variability and association with de novo donor-specific antibody formation in pediatric kidney transplant recipients.","volume":"17","author":"Piburn","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"R56-20260824","doi-asserted-by":"crossref","first-page":"e14297","DOI":"10.1111\/petr.14297","article-title":"Effects of tacrolimus intrapatient variability and CYP3A5 polymorphism on the outcomes of pediatric kidney transplantation.","volume":"26","author":"Choi","year":"2022","journal-title":"Pediatr Transplant"},{"key":"R57-20260824","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1007\/s00467-022-05426-3","article-title":"Association of intraindividual tacrolimus variability with de novo donor-specific HLA antibody development and allograft rejection in pediatric kidney transplant recipients with low immunological risk.","volume":"37","author":"Baghai Arassi","year":"2022","journal-title":"Pediatr Nephrol"},{"key":"R58-20260824","doi-asserted-by":"crossref","first-page":"1037566","DOI":"10.3389\/fimmu.2022.1037566","article-title":"Combined impact of the inter and intra-patient variability of tacrolimus blood level on allograft outcomes in kidney transplantation.","volume":"13","author":"Park","year":"2022","journal-title":"Front Immunol"},{"key":"R60-20260824","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias.","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"R61-20260824","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/S0041-1345(98)00374-1","article-title":"Trough cyclosporine concentration variability.","volume":"30","author":"Savoldi","year":"1998","journal-title":"Transplant Proc"},{"key":"R63-20260824","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1111\/ajt.15346","article-title":"Late intra-patient tacrolimus trough level variability as a major problem in kidney transplantation: a Collaborative Transplant Study Report.","volume":"19","author":"S\u00fcsal","year":"2019","journal-title":"Am J Transplant"},{"key":"R64-20260824","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00228-010-0810-9","article-title":"Explaining variability in ciclosporin exposure in adult kidney transplant recipients.","volume":"66","author":"Press","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"key":"R65-20260824","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2165\/00003088-200443100-00001","article-title":"Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.","volume":"43","author":"Staatz","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"R66-20260824","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2174\/0113892002328742241210102522","article-title":"Tacrolimus, cytochrome P450, interactions with food variables in organ transplant recipients; a current and comprehensive review.","volume":"25","author":"Tolou-Ghamari","year":"2025","journal-title":"Curr Drug Metab"},{"key":"R67-20260824","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/03602532.2016.1151037","article-title":"Clinical determinants of calcineurin inhibitor disposition: a mechanistic review.","volume":"48","author":"Vanhove","year":"2016","journal-title":"Drug Metab Rev"},{"key":"R68-20260824","doi-asserted-by":"crossref","first-page":"100842","DOI":"10.1016\/j.trre.2024.100842","article-title":"Tacrolimus intra-patient variability measures and its associations with allograft clinical outcomes in kidney transplantation.","volume":"38","author":"Xie","year":"2024","journal-title":"Transplant Rev (Orlando)"},{"key":"R69-20260824","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1080\/17425255.2021.1974399","article-title":"Comparing the pharmacokinetics of extended-release tacrolimus (LCP-TAC) to immediate-release formulations in kidney transplant patients.","volume":"17","author":"Tan","year":"2021","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"R70-20260824","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/FTD.0000000000000640","article-title":"Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report.","volume":"41","author":"Brunet","year":"2019","journal-title":"Ther Drug Monit"},{"key":"R71-20260824","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1038\/s41467-025-59739-6","article-title":"Tacrolimus dosing in liver transplant recipients using phenotypic personalized medicine: a phase 2 randomized clinical trial.","volume":"16","author":"Khong","year":"2025","journal-title":"Nat Commun"},{"key":"R72-20260824","doi-asserted-by":"crossref","first-page":"e088775","DOI":"10.1136\/bmjopen-2024-088775","article-title":"Analytical modelling techniques for enhancing tacrolimus dosing in solid organ transplantation: a systematic review protocol.","volume":"14","author":"Amooei","year":"2024","journal-title":"BMJ Open"},{"key":"R73-20260824","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/psp4.12946","article-title":"Physiologically based pharmacokinetic modeling of tacrolimus for food-drug and CYP3A drug-drug-gene interaction predictions.","volume":"12","author":"Loer","year":"2023","journal-title":"CPT Pharmacometrics Syst Pharmacol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0000000000005785","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:11:18Z","timestamp":1787577078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0000000000005785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":65,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005785","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]}}}